High Court Seeks US Views On Lamictal Pay-For-Delay Case
By Jeff Zalesin ( June 6, 2016, 12:06 PM EDT) -- The U.S. Supreme Court on Monday asked the U.S. solicitor general to weigh in on whether it should review a Third Circuit decision holding that the lack of a cash payment did not doom a pay-for-delay case against GlaxoSmithKline and Teva over the anti-convulsant Lamictal....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.